Compare · 3 funds side by side · dividends reinvested

VHT, IBRN and XLV

Story of the three · Growth5Y$10,000 five years agoDividends reinvested · all three on one scale$15,068XLV · best of the three

02 / 04

VHT, IBRN and XLV, Ranked

Today

FundFeeYieldYTD1 year3 yrs · yr5 yrs · yrWorst dropVolatilityAssetsAvg rank

State Street Health Care Select Sector SPDR ETFSectors · Health care0.08%1.39%+20.4%+29.7%+16.2%+8.5%−10.5%16.4%$49.1B1.5

Vanguard Health Care ETFSectors · Health care0.09%1.35%+19.6%+28.1%+16.9%+7.4%−10.4%15.8%$19.1B1.8

iShares Neuroscience and Healthcare ETFSectors · Health care0.47%0.96%+3.0%+11.3%+21.0%[…]−26.3%26.7%$7M2.7

Rank among the three1st → 3rdFee, drop and volatility: lower ranks higherAvg rank: mean of the 8 ranks · 1 is best

End-of-day Nov 3, 2026 · returns include dividends · since: VHT 2004 · IBRN 2022 · XLV 1998

Head to Head

Swap sides Versus in desk

Head to Head

Vanguard Health Care ETF · $19.1B$14,313

VHT

IBRN

iShares Neuroscience and Healthcare ETF · $7M[…]

$10,000 five years ago, dividends reinvested · they hold 1.3% in common

VHTMeasureIBRN

+19.6%Year to dateJan 1 → Nov 3+3.0%

+28.1%1 yearTotal return+11.3%

+16.9%3 years · per year$10,000 became $15,988 · $17,703+21.0%

+7.4%5 years · per year$10,000 became $14,313 · […][…]

0.09%Expense ratio$9 · $47 a year on $10k · lower is better0.47%

1.35%Trailing 12-mo yield$135 · $96 a year on $10k0.96%

−10.4%Worst dropSmaller is better−26.3%

15.8%VolatilityLower is calmer26.7%

VHTIBRN Winner of the row, in its colourEach row: the bigger of the two fills its side

6–1VHT wins

End-of-day Nov 3, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns

More Ways to See the Pairs

VHT vs IBRN: Top 5 Holdings

Today

VHT

37.8%in top 5

IBRN

in top 523.5%

VHTStockIBRN

12.9%LLYnot top 5

8.8%JNJnot top 5

6.5%ABBVnot top 5

not top 5BIIB5.6%

5.0%MRKnot top 5

not top 5ALKS4.8%

4.7%UNHnot top 5

not top 5NBIX4.6%

not top 5EWTX4.4%

not top 5PTCT4.2%

Held in common1.3%

End-of-day Nov 3, 2026 · share of each fund

VHT vs IBRN Returns, Every Period

VanguardVHT

+28.1%

past year

IBRNiShares

+11.3%

past year

VHTIBRNFaded: behind in that period

2–1VHT wins

End-of-day Nov 3, 2026 · dividends in · faded = behind in that period

VHT vs XLV

YTD

VanguardVHT

+19.6%

XLVSPDR

+20.4%

+19.6%Year to date+20.4%

−10.4%Worst drop · 1Y−10.5%

15.8%Volatility · 1Y16.4%

1.4%Yield1.4%

$19.1BAssets$49.1B

2–1VHT wins

End-of-day Nov 3, 2026 · smaller drop and lower volatility win

Cost, Income and Risk

Fees: VHT, IBRN, XLV

Today

0.08%lowest, XLV

FundExpense ratioFee$10k

XLV0.08%$8

VHT0.09%$9

IBRN0.47%$47

End-of-day Nov 3, 2026 · fee on $10,000 a year

Yields: VHT, IBRN, XLV

1.39%highest, XLV

FundTrailing yieldYield$10k

XLV1.39%$139

VHT1.35%$135

IBRN0.96%$96

End-of-day Nov 3, 2026 · trailing 12-month yield

Income After Fees on $10,000

$131most kept, XLV

XLV$139 − $8 = $131

VHT$135 − $9 = $126

IBRN$96 − $47 = $49

KeptFee

End-of-day Nov 3, 2026 · yield in dollars minus the fee

Overlap: VHT, IBRN, XLV

Today

85.2%most shared, VHT and XLV

VHTIBRNXLV

VHT—1.3%85.2%

IBRN1.3%—0.6%

XLV85.2%0.6%—

End-of-day Nov 3, 2026 · share held in common · outlined: the pair in versus

Return vs Bumpiness: 3 ETFs

+29.7%XLV, at 16.4% volatility

VHTWorst drop−10.4%15.8% vol

XLVWorst drop−10.5%16.4% vol

IBRNWorst drop−26.3%26.7% vol

End-of-day Nov 3, 2026 · up and left is better

Paid More vs Made More

YTD

XLVVHT

+20.4%Year to date+19.6%

1.4%Yield1.4%

+29.7%Past year+28.1%

0.08%Fee0.09%

3–0XLV wins

End-of-day Nov 3, 2026

Popular Pairs Near These Three

SCHD vs VIG

YTD

SchwabSCHD

+32.8%

VIGVanguard

+14.0%

+32.8%Year to date+14.0%

3.0%Yield1.5%

$121BAssets$109B

2–0SCHD wins

End-of-day Nov 3, 2026

JEPQ vs JEPI

YTD

J.P. MorganJEPQ

+7.5%

JEPIJ.P. Morgan

+7.0%

+7.5%Year to date+7.0%

12.3%Yield8.0%

$41.8BAssets$46.0B

2–0JEPQ wins

End-of-day Nov 3, 2026

SPYM vs SPY

YTD

SPDRSPYM

+11.5%

SPYSPDR

+11.5%

+11.5%Year to date+11.5%

1.0%Yield1.0%

$185BAssets$798B

0–0level

End-of-day Nov 3, 2026